E. L. and C. ,

E. L. , C. L. , D. M. , E. B. , and L. ,

H. , performed bioinformatics analyses

E. L. , C. L. , and H. ,

D. M. and G. S. , had overall medical oversight, provided patient samples and clinical data, performed clinical data analysis, and revised the manuscript

R. P. , L coordinated the CRYOSTEM Consortium and provided access to samples from cohort 1

E. L. , E. B. , G. S. , and L. ,

L. R. and G. S. , conceived the project, secured funding, and supervised the work; and all authors approved the final version of the manuscript. Conflict-of-interest disclosure: The authors declare no competing financial interests

H. V. ,

E. B. , , pp.0-0001

G. S. , , pp.0-0002

L. R. , Correspondence: Lars Rogge, Immunoregulation Unit, Department of Immunology, pp.0-0003

, e-mail: lars.rogge@pasteur.fr; and Gérard Socié, Service d'Hématologie Greffe, p.75010

C. Mcdonald-hyman, L. A. Turka, and B. R. Blazar, Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation, Sci Transl Med, vol.7, issue.280, pp.280-282, 2015.

G. Socié and B. R. Blazar, Acute graft-versus-host disease: from the bench to the bedside, Blood, vol.114, issue.20, pp.4327-4336, 2009.

R. Zeiser and B. R. Blazar, Acute graft-versus-host disease-biologic process, prevention, and therapy, N Engl J Med, vol.377, issue.22, pp.2167-2179, 2017.

L. A. Welniak, B. R. Blazar, and W. J. Murphy, Immunobiology of allogeneic hematopoietic stem cell transplantation, Annu Rev Immunol, vol.25, issue.1, pp.139-170, 2007.

A. D. Sung and N. J. Chao, Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment, Stem Cells Transl Med, vol.2, issue.1, pp.25-32, 2013.

M. A. Schroeder and J. F. Dipersio, Mouse models of graft-versus-host disease: advances and limitations, Dis Model Mech, vol.4, issue.3, pp.318-333, 2011.

R. Zeiser and B. R. Blazar, Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?, vol.128, p.1441, 2016.

, Blood, vol.127, issue.25, pp.3117-3126, 2016.

R. Seggewiss and H. Einsele, Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update, Blood, vol.115, pp.3861-3868, 2010.

G. Thangavelu and B. R. Blazar, Achievement of tolerance induction to prevent acute graft-vs.-host disease, Front Immunol, vol.10, p.309, 2019.

R. Zeiser and B. R. Blazar, Pathophysiology of chronic graft-versus-host disease and therapeutic targets, N Engl J Med, vol.377, issue.26, pp.2565-2579, 2017.

D. Michonneau, E. Latis, and E. Curis, Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites, Nat Commun, vol.10, issue.1, p.5695, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02626069

M. Coffre, M. Roumier, and M. Rybczynska, Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis, Arthritis Rheum, vol.65, issue.6, pp.1510-1521, 2013.

S. Dong, S. Maiella, and A. Xhaard, Multiparameter single-cell profiling of human CD41FOXP31 regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease, Blood, vol.122, issue.10, pp.1802-1812, 2013.

H. Yahia-cherbal, M. Rybczynska, and D. Lovecchio, NFAT primes the human RORC locus for RORgt expression in CD4 1 T cells, Nat Commun, vol.10, issue.1, p.5450, 2019.

, Nat Commun, vol.10, issue.1, p.4698, 2019.

M. Edinger, P. Hoffmann, and J. Ermann, CD41CD251 regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation, Nat Med, vol.9, issue.9, pp.1144-1150, 2003.

K. Matsuoka, H. T. Kim, and S. Mcdonough, Altered regulatory T cell homeostasis in patients with CD41 lymphopenia following allogeneic hematopoietic stem cell transplantation, J Clin Invest, vol.120, issue.5, pp.1479-1493, 2010.

G. Yaari, C. R. Bolen, J. Thakar, and S. H. Kleinstein, Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations, Nucleic Acids Res, vol.41, issue.18, p.170, 2013.

A. Liberzon, A. Subramanian, R. Pinchback, H. Thorvaldsdóttir, P. Tamayo et al., Molecular signatures database (MSigDB) 3.0, Bioinformatics, vol.27, issue.12, pp.1739-1740, 2011.

A. Crawford, J. M. Angelosanto, and C. Kao, Molecular and transcriptional basis of CD4 1 T cell dysfunction during chronic infection, Immunity, vol.40, issue.2, pp.289-302, 2014.

K. Man, S. S. Gabriel, and Y. Liao, Transcription factor IRF4 promotes CD8(1) T cell exhaustion and limits the development of memory-like T cells during chronic infection, Immunity, vol.47, issue.6, pp.1129-1141, 2017.

E. B. Thorp, C. Stehlik, and M. J. Ansari, T-cell exhaustion in allograft rejection and tolerance, Curr Opin Organ Transplant, vol.20, issue.1, pp.37-42, 2015.

E. J. Wherry, T cell exhaustion, Nat Immunol, vol.12, issue.6, pp.492-499, 2011.

J. W. Griffith, C. L. Sokol, and A. D. Luster, Chemokines and chemokine receptors: positioning cells for host defense and immunity, Annu Rev Immunol, vol.32, issue.1, pp.659-702, 2014.

N. P. Weng, Y. Araki, and K. Subedi, The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation, Nat Rev Immunol, vol.12, issue.4, pp.306-315, 2012.

T. Willinger, T. Freeman, H. Hasegawa, A. J. Mcmichael, and M. F. Callan, Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets, J Immunol, vol.175, issue.9, pp.5895-5903, 2005.

T. Willinger, T. Freeman, M. Herbert, H. Hasegawa, A. J. Mcmichael et al., Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo, J Immunol, vol.176, issue.3, pp.1439-1446, 2006.

Y. Zhang, G. Joe, E. Hexner, J. Zhu, and S. G. Emerson, Host-reactive CD81 memory stem cells in graft-versus-host disease, Nat Med, vol.11, issue.12, pp.1299-1305, 2005.

A. Hutloff, A. M. Dittrich, and K. C. Beier, ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28, Nature, vol.397, issue.6716, pp.263-266, 1999.

C. H. Chang, J. D. Curtis, and L. B. Maggi, Posttranscriptional control of T cell effector function by aerobic glycolysis, Cell, vol.153, issue.6, pp.1239-1251, 2013.

L. Chen and D. B. Flies, Molecular mechanisms of T cell co-stimulation and co-inhibition, Nat Rev Immunol, vol.13, issue.7, p.542, 2013.

, Nat Rev Immunol, vol.13, issue.4, pp.227-242, 2013.

X. Kang, J. Kim, and M. Deng, Inhibitory leukocyte immunoglobulin-like receptors: immune checkpoint proteins and tumor sustaining factors, Cell Cycle, vol.15, issue.1, pp.25-40, 2016.

K. M. Murphy, C. A. Nelson, and J. R. Sedý, Balancing co-stimulation and inhibition with BTLA and HVEM, Nat Rev Immunol, vol.6, issue.9, pp.671-681, 2006.

P. M. Odorizzi and E. J. Wherry, Inhibitory receptors on lymphocytes: insights from infections, J Immunol, vol.188, issue.7, pp.2957-2965, 2012.

M. Saraiva, O. Garra, and A. , The regulation of IL-10 production by immune cells, Nat Rev Immunol, vol.10, issue.3, pp.170-181, 2010.

A. W. Goldrath and M. J. Bevan, Low-affinity ligands for the TCR drive proliferation of mature CD81 T cells in lymphopenic hosts, Immunity, vol.11, issue.2, pp.183-190, 1999.

N. K. Tchao and L. A. Turka, Lymphodepletion and homeostatic proliferation: implications for transplantation, Am J Transplant, vol.12, issue.5, pp.1079-1090, 2012.

P. J. Podgorny, Y. Liu, and P. Dharmani-khan, Immune cell subset counts associated with graft-versus-host disease, Biol Blood Marrow Transplant, vol.20, issue.4, pp.450-462, 2014.

L. Stern, H. Mcguire, and S. Avdic, Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation, Front Immunol, vol.9, p.1672, 2018.

S. Thiant, M. M. Moutuou, D. Leboeuf, and M. Guimond, Homeostatic cytokines in immune reconstitution and graft-versus-host disease, Cytokine, vol.82, pp.24-32, 2016.

D. Bock, M. Fillet, M. Hannon, and M. , Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioning, PLoS One, vol.8, issue.2, p.55876, 2013.

T. Ito, S. Hanabuchi, and Y. H. Wang, Two functional subsets of FOXP31 regulatory T cells in human thymus and periphery, Immunity, vol.28, issue.6, pp.870-880, 2008.

K. Wing, Y. Onishi, and P. Prieto-martin, CTLA-4 control over Foxp31 regulatory T cell function, Science, vol.322, issue.5899, pp.271-275, 2008.

G. K. Geiss, R. E. Bumgarner, and B. Birditt, Direct multiplexed measurement of gene expression with color-coded probe pairs, Nat Biotechnol, vol.26, issue.3, pp.317-325, 2008.

L. Gattinoni, E. Lugli, and Y. Ji, A human memory T cell subset with stem cell-like properties, Nat Med, vol.17, issue.10, pp.1290-1297, 2011.

L. Gattinoni, D. E. Speiser, M. Lichterfeld, and C. Bonini, T memory stem cells in health and disease, Nat Med, vol.23, issue.1, pp.18-27, 2017.

C. Baron, R. Somogyi, and L. D. Greller, Prediction of graft-versus-host disease in humans by donor gene-expression profiling, PLoS Med, vol.4, issue.1, p.23, 2007.

M. P. Buzzeo, J. Yang, G. Casella, and V. Reddy, A preliminary gene expression profile of acute graft-versus-host disease, Cell Transplant, vol.17, issue.5, pp.489-494, 2008.

N. Takahashi, N. Sato, S. Takahashi, and A. Tojo, Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation, Exp Hematol, vol.36, issue.12, pp.1760-1770, 2008.

J. Verner, J. Kabathova, and A. Tomancova, Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation, Exp Hematol, vol.40, issue.11, pp.899-905, 2012.

H. Oh and S. Ghosh, NF-kB: roles and regulation in different CD4(1) T-cell subsets, Immunol Rev, vol.252, issue.1, pp.41-51, 2013.

S. Vodanovic-jankovic, P. Hari, P. Jacobs, R. Komorowski, and W. R. Drobyski, NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145, Blood, vol.107, issue.2, pp.827-834, 2006.

C. E. Widjaja, J. G. Olvera, and P. J. Metz, Proteasome activity regulates CD81 T lymphocyte metabolism and fate specification, J Clin Invest, vol.127, issue.10, pp.3609-3623, 2017.

J. Li, K. Semple, and W. K. Suh, Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice, Biol Blood Marrow Transplant, vol.17, issue.7, pp.962-969, 2011.

P. A. Taylor, A. Panoskaltsis-mortari, and G. J. Freeman, Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM), Blood, vol.105, issue.8, pp.3372-3380, 2005.

A. Burlion, S. Brunel, N. Y. Petit, D. Olive, and G. Marodon, Targeting the human T-cell inducible costimulator molecule with a monoclonal antibody prevents graft-vs-host disease and preserves graft vs leukemia in a xenograft murine model, Front Immunol, vol.8, p.756, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01564950